Position in TAK
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$80,432
-$31,473 QoQ
Shares Held
4,343
-39.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Arax Advisory Partners holds $1,784,999 across 41 Drug Manufacturers - Specialty & Generic names. TAK ranks #6 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
681 | $403,819 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
10,694 | $322,103 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
1,432 | $188,651 | |
| 4 | ZTS |
Zoetis Inc.
|
1,527 | $180,506 | |
| 5 | VTRS |
Viatris Inc
|
10,932 | $147,691 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
4,343 | $80,432 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
1,030 | $79,207 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
2,408 | $57,623 |
All Filings in TAK
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $80,432 | 4,343 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $111,905 | 7,178 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $895,587 | 61,174 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,950 | 773 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,479 | 234 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $22,126 | 1,556 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $24,766 | 1,914 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $27,168 | 1,956 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $21,918 | 1,536 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $23,699 | 1,532 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $24,570 | 1,564 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $18,984 | 1,152 | Shares | Sole | 2023-05-16 | |
| 2022-03-31 | $2,878 | 201 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,376 | 101 | Shares | Sole | 2022-02-08 | |
| 2021-06-30 | $39,920 | 2,372 | Shares | Sole | 2021-08-02 | |
| 2020-12-31 | $40,040 | 2,200 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $39,248 | 2,200 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $39,446 | 2,200 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $33,396 | 2,200 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||